Investigational Drug Information for Dapivirine
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Dapivirine?
Dapivirine is an investigational drug.
There have been 42 clinical trials for Dapivirine.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Infections. The leading clinical trial sponsors are International Partnership for Microbicides, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and National Institutes of Health (NIH).
There are three hundred and twenty-five US patents protecting this investigational drug and four international patents.
Summary for Dapivirine
| US Patents | 325 |
| International Patents | 4,901 |
| US Patent Applications | 711 |
| WIPO Patent Applications | 429 |
| Japanese Patent Applications | 288 |
| Clinical Trial Progress | Phase 3 (2016-03-01) |
| Vendors | 87 |
Recent Clinical Trials for Dapivirine
| Title | Sponsor | Phase |
|---|---|---|
| Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008 | International Partnership for Microbicides, Inc. | Phase 1 |
| Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
Clinical Trial Summary for Dapivirine
Top disease conditions for Dapivirine
Top clinical trial sponsors for Dapivirine
US Patents for Dapivirine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dapivirine | See Plans and Pricing | Use of solid carrier particles to improve the processability of a pharmaceutical agent | Gilead Sciences, Inc. (Foster City, CA) | See Plans and Pricing |
| Dapivirine | See Plans and Pricing | Combination formulation of two antiviral compounds | Gilead Pharmasset LLC (Foster City, CA) | See Plans and Pricing |
| Dapivirine | See Plans and Pricing | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits | ELIAN LLC (Monrovia, CA) | See Plans and Pricing |
| Dapivirine | See Plans and Pricing | Compounds and combinations for the treatment of HIV | Gilead Sciences, Inc. (Foster City, CA) | See Plans and Pricing |
| Dapivirine | See Plans and Pricing | Substituted thiazoles as HIV integrase inhibitors | Japan Tobacco Inc. (Tokyo, JP) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dapivirine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dapivirine | African Regional IP Organization (ARIPO) | AP3089 | 2028-05-02 | See Plans and Pricing |
| Dapivirine | African Regional IP Organization (ARIPO) | AP3250 | 2028-05-02 | See Plans and Pricing |
| Dapivirine | Argentina | AR075369 | 2028-05-02 | See Plans and Pricing |
| Dapivirine | Australia | AU2009242451 | 2028-05-02 | See Plans and Pricing |
| Dapivirine | Australia | AU2010210598 | 2028-05-02 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
